Home
Home

Momenta

Momenta pleads for Supreme Court review in Lovenox generic case

Momenta pleads for Supreme Court review in Lovenox generic case
Fierce Pharma

Momenta Pharmaceuticals sticks to guidance despite revenue plunge

Momenta Pharmaceuticals sticks to guidance despite revenue plunge
bizjournals

3 Things to Watch at Momenta Pharmaceuticals

3 Things to Watch at Momenta Pharmaceuticals
Motley Fool

The Worst of 2012: Momenta Pharmaceuticals

The Worst of 2012: Momenta Pharmaceuticals
Motley Fool

A Good Start on the Biosimilar Front

A Good Start on the Biosimilar Front
Motley Fool

2012 Biotech Stock Predictions: An Interim Report Card

2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com

4 Small-Cap Biotech Stocks Generating Profits With Buy Ratings

4 Small-Cap Biotech Stocks Generating Profits With Buy Ratings
Seeking Alpha

Momenta Loses In Appeals Court Over Watson’s Lovenox Copy

Momenta Loses In Appeals Court Over Watson’s Lovenox Copy
Bloomberg

Momenta Pharmaceuticals Acknowledges Federal Circuit Opinion Supporting Order Issued January 26, 2012 in Ongoing Suit Against Amphastar Pharmaceuticals and Watson Pharmaceuticals

Momenta Pharmaceuticals Acknowledges Federal Circuit Opinion Supporting Order Issued January 26, 2012 in Ongoing Suit Against Amphastar Pharmaceuticals and Watson Pharmaceuticals
Yahoo/GlobeNewsWire

Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?

Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha